
Integra LifeSciences Holdings Corporation IART
$ 13.82
5.1%
Quarterly report 2025-Q2
added 07-31-2025
Integra LifeSciences Holdings Corporation EBITDA per Share 2011-2026 | IART
Annual EBITDA per Share Integra LifeSciences Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.92 | 1.9 | 3.36 | 2.79 | 2.29 | 2.16 | 1.57 | 0.831 | 1.73 | 1.21 | 1.19 | 0.982 | 1.65 | 1.33 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.36 | 0.831 | 1.71 |
Quarterly EBITDA per Share Integra LifeSciences Holdings Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.64 | -0.15 | -0.06 | 0.01 | 0.18 | 0.37 | 0.19 | 0.48 | - | 0.82 | 0.76 | 0.6 | - | 0.71 | 0.66 | 0.42 | - | 0.78 | 0.26 | 0.66 | - | -0.18 | 1.17 | 0.7 | - | 1.25 | 0.99 | 0.67 | - | 0.93 | 0.76 | 0.4 | - | 1.13 | 0.79 | 0.55 | - | 1.43 | 1.47 | 1.01 | - | 1.58 | 1.28 | 0.7 | - | 0.16 | 1.06 | 0.33 | - | 2.07 | 1.54 | 1.06 | - | 1.95 | 1.1 | 1.04 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.07 | -6.64 | 0.613 |
EBITDA per Share of other stocks in the Medical devices industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
5.62 K | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
-0.4 | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
-0.2 | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
-0.74 | - | - | $ 475 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-1.24 | - | - | $ 1.77 B | ||
|
Cognyte Software Ltd.
CGNT
|
0.12 | $ 9.57 | 0.31 % | $ 687 M | ||
|
Alphatec Holdings
ATEC
|
-0.4 | $ 22.72 | 3.41 % | $ 3.25 B | ||
|
Lianluo Smart Limited
LLIT
|
2.46 | - | 24.59 % | $ 44.8 M | ||
|
AxoGen
AXGN
|
0.07 | $ 32.99 | 0.12 % | $ 1.46 B | ||
|
Axonics Modulation Technologies
AXNX
|
-1.14 | - | - | $ 3.31 B | ||
|
Apyx Medical Corporation
APYX
|
-0.48 | $ 3.49 | 0.72 % | $ 121 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-0.341 | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
14.9 | $ 316.68 | -2.3 % | $ 8.93 B | ||
|
BioSig Technologies
BSGM
|
-0.9 | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
2.63 | $ 99.0 | 0.36 % | $ 146 B | ||
|
Conformis
CFMS
|
-5.85 | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
2.93 M | $ 52.05 | -1.81 % | $ 7.76 K | ||
|
Abbott Laboratories
ABT
|
4.69 | $ 126.3 | -0.58 % | $ 220 B | ||
|
CONMED Corporation
CNMD
|
7.03 | $ 44.57 | 2.65 % | $ 1.37 B | ||
|
EDAP TMS S.A.
EDAP
|
-0.48 | $ 3.71 | -2.37 % | $ 138 M | ||
|
CryoLife, Inc.
CRY
|
0.827 | - | -4.14 % | $ 702 M | ||
|
Cardiovascular Systems
CSII
|
-0.82 | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-7.45 | - | -10.19 % | $ 1.99 M | ||
|
CHF Solutions, Inc.
CHFS
|
-0.207 | - | 1.15 % | $ 34.5 M | ||
|
Soliton, Inc.
SOLY
|
-0.544 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.59 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
0.999 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-0.2 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-0.49 | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
-0.24 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-26.8 | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
1.27 | $ 28.83 | -1.08 % | $ 244 M | ||
|
Intersect ENT, Inc.
XENT
|
-1.79 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
-442 | - | -0.97 % | $ 54.4 M | ||
|
InMode Ltd.
INMD
|
1.43 | $ 14.29 | -8.66 % | $ 1.13 B | ||
|
GBS
GBS
|
-1.83 | - | -0.57 % | $ 7.12 M | ||
|
Align Technology
ALGN
|
10.1 | $ 170.77 | 2.37 % | $ 12.8 B | ||
|
Accuray Incorporated
ARAY
|
0.14 | $ 0.9 | 3.41 % | $ 92.5 M | ||
|
Avinger
AVGR
|
-20.8 | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-0.69 | $ 15.28 | -0.07 % | $ 413 M | ||
|
FONAR Corporation
FONR
|
1.5 | $ 18.56 | 0.08 % | $ 122 M | ||
|
Globus Medical
GMED
|
3.09 | $ 94.68 | 4.58 % | $ 12.9 B | ||
|
Aziyo Biologics
AZYO
|
-1.47 | - | 1.37 % | $ 20.5 M | ||
|
IRIDEX Corporation
IRIX
|
-0.55 | $ 1.21 | 1.6 % | $ 19.5 M | ||
|
IRadimed Corporation
IRMD
|
1.8 | $ 99.94 | 1.63 % | $ 1.27 B | ||
|
Establishment Labs Holdings
ESTA
|
-1.61 | $ 72.94 | 4.19 % | $ 2.05 B | ||
|
Invacare Corporation
IVC
|
-1.78 | - | - | $ 24.7 M | ||
|
Cytosorbents Corporation
CTSO
|
-0.28 | $ 0.68 | -0.49 % | $ 37 M | ||
|
Integer Holdings Corporation
ITGR
|
9.5 | $ 83.33 | 3.13 % | $ 2.8 B |